Arbutus Biopharma (ABUS) News Today $3.13 0.00 (0.00%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$3.15 +0.02 (+0.64%) As of 07/16/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABUS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Arbutus Biopharma Corporation (ABUS) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comArbutus Biopharma (NASDAQ:ABUS) Stock Price Down 2.8% - Time to Sell?June 26, 2025 | marketbeat.comArbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical FocusJune 25, 2025 | globenewswire.comArbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 13, 2025 | marketbeat.comBank of America Corp DE Acquires 171,906 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)June 7, 2025 | marketbeat.comMillennium Management LLC Purchases 92,068 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)June 5, 2025 | marketbeat.comDeutsche Bank AG Buys 75,212 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)May 30, 2025 | marketbeat.comWoodline Partners LP Has $3.18 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS)May 27, 2025 | marketbeat.comNorthern Trust Corp Has $4.35 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS)May 24, 2025 | marketbeat.comArbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Two Seas Capital LPMay 23, 2025 | marketbeat.comArbutus Biopharma Co. (NASDAQ:ABUS) is Whitefort Capital Management LP's Largest PositionMay 22, 2025 | marketbeat.comArbutus Biopharma Co. (NASDAQ:ABUS) Shares Acquired by Saba Capital Management L.P.May 19, 2025 | marketbeat.comArbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal ProgressMay 18, 2025 | msn.comHudson Bay Capital Management LP Boosts Position in Arbutus Biopharma Co. (NASDAQ:ABUS)May 15, 2025 | marketbeat.comArbutus Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comArbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025May 10, 2025 | msn.comArbutus Biopharma (NASDAQ:ABUS) Trading Down 6% - Here's What HappenedMay 7, 2025 | marketbeat.comArbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025May 7, 2025 | globenewswire.comSusquehanna Fundamental Investments LLC Buys Shares of 202,541 Arbutus Biopharma Co. (NASDAQ:ABUS)May 5, 2025 | marketbeat.comArbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by Boothbay Fund Management LLCMay 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 1,250,000 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)May 1, 2025 | marketbeat.comTwo Seas Capital LP Purchases 353,568 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)April 27, 2025 | marketbeat.comArbutus Biopharma (ABUS) to Release Quarterly Earnings on ThursdayApril 26, 2025 | marketbeat.comJPMorgan Chase & Co. Has $2.93 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS)April 25, 2025 | marketbeat.comBlackBarn Capital Partners LP Buys 270,971 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)April 24, 2025 | marketbeat.comArbutus Biopharma Showcases Promising Hepatitis B Research at EASL CongressApril 24, 2025 | msn.comArbutus Biopharma (NASDAQ:ABUS) Trading Up 4.8% - What's Next?April 23, 2025 | marketbeat.comArbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025April 23, 2025 | globenewswire.comFranklin Resources Inc. Takes $301,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS)April 21, 2025 | marketbeat.comQuinn Opportunity Partners LLC Buys 169,747 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)April 14, 2025 | marketbeat.comArbutus Biopharma (NASDAQ:ABUS) Shares Down 6.3% - Here's What HappenedApril 9, 2025 | marketbeat.comADAR1 Capital Management LLC Decreases Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS)April 9, 2025 | marketbeat.comRangeley Capital LLC Acquires Shares of 1,459,000 Arbutus Biopharma Co. (NASDAQ:ABUS)April 5, 2025 | marketbeat.comArbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.comMarch 30, 2025 | marketbeat.comArbutus Biopharma (NASDAQ:ABUS) Issues Quarterly Earnings ResultsMarch 29, 2025 | marketbeat.comArbutus Biopharma (NASDAQ:ABUS) Trading 4.1% Higher Following Strong EarningsMarch 29, 2025 | marketbeat.comChardan Capital Reaffirms "Buy" Rating for Arbutus Biopharma (NASDAQ:ABUS)March 29, 2025 | marketbeat.comArbutus Biopharma Reports 2024 Financial Results and Strategic UpdatesMarch 28, 2025 | msn.comArbutus Biopharma: A Wing And A PrayerMarch 28, 2025 | seekingalpha.comWhat is Chardan Capital's Estimate for ABUS FY2025 Earnings?March 28, 2025 | marketbeat.comArbutus Biopharma reports FY24 EPS (38c), consensus (55c)March 28, 2025 | markets.businessinsider.comArbutus Biopharma reduced workforce by 57%March 28, 2025 | markets.businessinsider.comArbutus Biopharma Cuts Workforce by More Than Half, Hires New CFO in Exec ShuffleMarch 27, 2025 | marketwatch.comArbutus announces a 57% workforce reductionMarch 27, 2025 | msn.comArbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comCorbin Capital Partners L.P. Sells 170,817 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS)March 22, 2025 | marketbeat.comArbutus Biopharma Co. (NASDAQ:ABUS) Sees Significant Increase in Short InterestMarch 20, 2025 | marketbeat.comArbutus Biopharma (NASDAQ:ABUS) Trading Up 6.3% - Here's What HappenedMarch 14, 2025 | marketbeat.comStockNews.com Downgrades Arbutus Biopharma (NASDAQ:ABUS) to SellMarch 13, 2025 | marketbeat.comChardan Capital Has Negative Outlook of ABUS FY2025 EarningsMarch 8, 2025 | marketbeat.com Get Arbutus Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABUS and its competitors with MarketBeat's FREE daily newsletter. Email Address ABUS Media Mentions By Week ABUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABUS News Sentiment▼1.890.95▲Average Medical News Sentiment ABUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABUS Articles This Week▼13▲ABUS Articles Average Week Get Arbutus Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHC News AGIO News TWST News INDV News RXRX News DNLI News BEAM News KNSA News BLTE News CNTA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABUS) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbutus Biopharma Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbutus Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABUS Stock Alerts